School of Medicine
Medical tablets, capsules and caplets flying out of a bottle against a light blue background


Chris Hollis

Professor of Child & Adolescent Psychiatry and Director, NIHR MindTech MIC, Faculty of Medicine & Health Sciences



Chris Hollis is Professor of Child & Adolescent Psychiatry at the University of Nottingham, Director of the NIHR MindTech MedTech Co-operative and leads the NIHR Nottingham BRC Mental Health and Technology Theme. His is Principal Investigator on the HTA ORBIT (Online Remote Behavioural Intervention for Tics) trial and led the HTA funded evidence-synthesis and systematic review of treatments for tics in children and young people (Hollis et al. Health Technol Assess, 2016. 20, 1-450) and the AQUA trial of QbTest for ADHD (Hollis et al. Journal of Child Psychology and Psychiatry. 2018 Dec;59(12):1298-1308).

Chris trained in psychiatry at the Maudsley Hospital and Institute of Psychiatry, where he was awarded an MRC Training Fellowship and completed his PhD on the long-term adult outcome adolescent-onset psychosis. He works as a Consultant in Developmental Neuropsychiatry with Nottinghamshire Healthcare NHS Foundation Trust and leads a regional lifespan neurodevelopmental service, including a Tourette's Clinic and Adult ADHD Clinic based at Queen's Medical Centre. His clinical and research interests include ADHD, Tourette syndrome, early onset schizophrenia and the development, evaluation and implementation of digital technologies to support better mental health.

As Director of MindTech, Chris is passionate about harnessing digital technology and building its evidence-base in mental healthcare by bringing together patients, clinicians, academics and technology developers. In 2020, Chris was a contributor to the 2020 World Innovation Summit for Health (WISH) report: The digital mental health revolution: Transforming care through innovation and scale-up. He was the recipient of the Association of Child of Child & Adolescent Mental Health (ACAMH) Digital Innovation Award 2020. He recently led the James Lind Alliance priority Setting Partnership's Top 10 research priorities for digital technology in mental healthcare (Hollis et al. Lancet Psychiatry. 2018 Oct;5(10):845-854). Chris chaired the NICE Guideline for schizophrenia and psychosis in children and young people (2011-13) and was a member of the 2018 NICE ADHD (Update) Guideline Committee. He is a member of Innovate UK's Digital Health Strategy Group. In 2015, Chris received a prestigious NIHR Senior Investigator Award. This distinguished accolade was awarded for a further 4 years in April 2019.

Expertise Summary


ADHD, Tourette's syndrome,

Research Summary

Child and adolescent psychiatry; Childhood-onset schizophrenia; Childhood-onset psychoses; Attention deficit/ hyperactivity disorder (ADHD); Tourette's syndrome; Paediatric… read more

Selected Publications

Current Research

  • Child and adolescent psychiatry;
  • Childhood-onset schizophrenia;
  • Childhood-onset psychoses;
  • Attention deficit/ hyperactivity disorder (ADHD);
  • Tourette's syndrome;
  • Paediatric psychopharacology;
  • Developmental neuropsychiatry.

Future Research

  • High-risk studies of early onset psychoses using neuropsychological, ERP and fMRI as predictors.
  • Animal models of ADHD.
  • Population genetic studies of ADHD - linking symptom dimensions, cognitive deficits and genetic risk.

School of Medicine

University of Nottingham
Medical School
Nottingham, NG7 2UH

Contacts: Call 0115 823 0031 ext.30031 or please see our 'contact us' page for further details